Target intelligence / Profile preview

Short coiled-coil protein (SCOC)

Target
SCOC
Molecular classification
Coiled-coil domain protein
01

Overview

Short coiled-coil protein (SCOC) is a small, widely expressed human protein containing a parallel left-handed coiled-coil domain. SCOC is primarily known for forming a complex with fasciculation and elongation protein zeta 1 (FEZ1); this complex is important for the regulation of autophagy and for axonal outgrowth and presynaptic organization, especially in neuronal tissues. SCOC acts as an effector of the Golgi resident GTPase Arl1 and physiologically is most abundant in brain, heart, and skeletal muscle. The coiled-coil domain is highly conserved, facilitating dimerization and critical protein-protein interactions. In *C. elegans*, loss or mutation of the SCOC homolog (UNC-69) results in severe neurodevelopmental defects, suggesting an essential role in neural circuit formation. There are at least four known human SCOC isoforms with variable N-termini but a conserved coiled-coil region. Current evidence does not indicate direct roles for SCOC as a classical drug target or as a biomarker, and no drugs are reported to interact with this protein. SCOC is not a receptor, enzyme, or transporter, but rather a structural interaction hub involved in essential cell biological processes. No approved drugs or drugs in development are currently reported to modulate SCOC or its direct pathway. Its role in human disease is primarily inferred from model organisms and relates to neural development and autophagy, but there is no strong evidence for a direct association with major clinical diseases in humans. Referenced information is synthesized primarily from crystal structure studies and functional investigations in human cells and model organisms.

Other names
SCOCOHRIHFB2072UNC-69
02

Biological functions

Positive regulation of autophagyAxonal outgrowthVesicular transport (through interaction with FEZ1)Protein-protein interaction scaffolding
03

Disease associations

Neurodevelopmental defects (evidence from *C. elegans* for axonal growth and presynaptic organization)No direct evidence for major human diseases

Beyond the preview

Go deeper on Short coiled-coil protein (SCOC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Short coiled-coil protein (SCOC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call